BSP:PFRM3's EV-to-FCF is ranked better than 85.14% of 74
companies
in the Medical Distribution industry
Industry Median: 16.97
vs BSP:PFRM3: 5.53
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Profarma Distribuidora De Produtos Farmaceuticos's PE Ratio (TTM) for today is calculated as:
Profarma Distribuidora De Produtos Farmaceuticos's share price for today is R$6.72.
Profarma Distribuidora De Produtos Farmaceuticos's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0.862.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Profarma Distribuidora De Produtos Farmaceuticos EV-to-FCF Related Terms
Profarma Distribuidora De Produtos Farmaceuticos EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Profarma Distribuidora De Produtos Farmaceuticos EV-to-FCF Chart
Profarma Distribuidora De Produtos Farmaceuticos Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profarma Distribuidora De Produtos Farmaceuticos EV-to-FCF vs Medical Distribution Industry
Profarma Distribuidora De Produtos Farmaceuticos's current Enterprise Value is R$2,397 Mil.
Profarma Distribuidora De Produtos Farmaceuticos's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$433 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) has a EV-to-FCF of 5.53 as of Jul. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. This is near median its historical median of 5.88. According to the industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #11 out of 74 companies in the Medical Distribution industry, placing it in the top 14.9%.
Is Profarma Distribuidora De Produtos Farmaceuticos' EV-to-FCF too high?
Profarma Distribuidora De Produtos Farmaceuticos' current EV-to-FCF of 5.53 is near median its 10-year median of 5.88. The Medical Distribution industry median EV-to-FCF is 16.97. Profarma Distribuidora De Produtos Farmaceuticos' value of 5.53 is 67.4% below this industry median. Based on the distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #11 out of 74 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Profarma Distribuidora De Produtos Farmaceuticos has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Profarma Distribuidora De Produtos Farmaceuticos' EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #11 out of 74 companies for EV-to-FCF. This places Profarma Distribuidora De Produtos Farmaceuticos in the top 15% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 16.97. Profarma Distribuidora De Produtos Farmaceuticos' value of 5.53 is 67.4% below this benchmark. While the company's 10-year median is 5.88 vs. the industry median of 16.97, Profarma Distribuidora De Produtos Farmaceuticos has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.97, based on 74 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Profarma Distribuidora De Produtos Farmaceuticos's current EV-to-FCF of 5.53 is 67.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profarma Distribuidora De Produtos Farmaceuticos's current EV-to-FCF is 5.53, which is near median its own 10-year median of 5.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profarma Distribuidora De Produtos Farmaceuticos stock overvalued right now?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.03, compared to a current price of R$6.72 — trading 16.3% below its estimated fair value. The current EV-to-FCF is 5.53, which is near median its 10-year median of 5.88 and 67.4% below the Medical Distribution industry median of 16.97. Profarma Distribuidora De Produtos Farmaceuticos' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3), the current EV-to-FCF is 5.53 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Overvalued in 2026?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos stock appears to be undervalued.
The current stock price of R$6.72 is trading 16.3% below its estimated GF Value™ of R$8.03.
GuruFocus considers Profarma Distribuidora De Produtos Farmaceuticos to be Modestly Undervalued.
Key valuation signals for BSP:PFRM3:
EV-to-FCF: 5.53 (near median its 10-year median of 5.88)
GF Value™: R$8.03 vs. price of R$6.72 (16.3% below fair value)
Industry Position: 67.4% below the Medical Distribution median (#11 of 74)
No single metric tells the full story. See the BSP:PFRM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Profarma Distribuidora De Produtos Farmaceuticos Business Description
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
75GF Score
Get the complete analysis for BSP:PFRM3
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PFRM3 has been successfully added to your 
